EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC 4.0

The efficacy of topical imiquimod in high‐grade cervical intraepithelial neoplasia: A systematic review and meta‐analysis

A J M van de Sande iD, M Kengsakul iD, M M Koeneman iD, M Jozwiak iD, C G Gerestein iD, A J Kruse iD, E M G van Esch iD, P J de Vos van Steenwijk iD, C L P Muntinga iD, W M Bramer iD, H C van Doorn iD, F J van Kemenade iD und 1 weitere

International Journal of Gynecology & Obstetrics · 2024-01 · 164 (1) · 66-74

DOI: 10.1002/ijgo.14953 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 23.06.2023. Verfasst von A J M van de Sande und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecological Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Uterine Cervical Dysplasia. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

A major side effect of cervical excision for high‐grade cervical intraepithelial neoplasia (CIN) is premature birth. A non‐invasive treatment for reproductive age women is warranted. The aim of the present study was to determine the efficacy of topical imiquimod in the treatment of high‐grade CIN, defined as a regression to ≤CIN 1, and to determine the clearance rate of high‐risk human papillomavirus (hr‐HPV), compared with surgical treatment and placebo.

Methods

Databases were searched for articles from their inception to February 2023.The study protocol number was INPLASY2022110046. Original studies reporting the efficacy of topical imiquimod in CIN 2, CIN 3 or persistent hr‐HPV infections were included. The study followed the Preferred Reporting Items for Systematic Reviews and Meta‐analyses checklist.

Results

Five studies were included ( n = 463). Histological regression to ≤CIN 1 was 55% in imiquimod versus 29% in placebo, and 93% in surgical treatment. Imiquimod‐treated women had a greater odds of histological regression to ≤CIN 1 than placebo (odds ratio [OR] 4.17, 95% confidence interval [CI] 2.03–8.54). In comparison to imiquimod, surgical treatment had an OR of 14.81(95% CI 6.59–33.27) for histological regression to ≤CIN 1. The hr‐HPV clearance rate was 53.4% after imiquimod and 66% after surgical treatment (95% CI 0.62–23.77).

Conclusions

The histological regression rate is highest for surgical treatment followed by imiquimod treatment and placebo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsPapillomavirus InfectionsUterine Cervical DysplasiaFemaleHumansImiquimodCervix UteriPapillomaviridae

Stichwörter der Autor:innen

LLETZmetabolic clearance ratepapillomaviridaepapillomavirus infectionssquamous intraepithelial lesionstransformation zonetreatment outcomeuterine cervical neoplasms

Substanzen

Imiquimod

Autor:innen und Institutionen

  • Department of Gynecological Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Panyananthaphikkhu Chonprathan Medical Center, Department of Obstetrics and Gynecology, Srinakharinwirot University, Nonthaburi, Thailand.
  • Department of Obstetrics and Gynecology, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Department of Gynecologic Oncology, Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Department of Obstetrics and Gynecology, Isala Clinics, Zwolle, The Netherlands.
  • Department of Obstetrics and Gynecology, Catharina Cancer Institute, Catharina Hospital, Eindhoven, The Netherlands.

ORCID-Profile: A J M van de Sande, M Kengsakul, M M Koeneman, M Jozwiak, C G Gerestein, A J Kruse, E M G van Esch, P J de Vos van Steenwijk, C L P Muntinga, W M Bramer, H C van Doorn, F J van Kemenade, H J van Beekhuizen

Zitieren

APA

van de Sande, A. J. M., Kengsakul, M., Koeneman, M. M., Jozwiak, M., Gerestein, C. G., Kruse, A. J., van Esch, E. M. G., de Vos van Steenwijk, P. J., Muntinga, C. L. P., Bramer, W. M., van Doorn, H. C., van Kemenade, F. J., & van Beekhuizen, H. J. (2024). The efficacy of topical imiquimod in high‐grade cervical intraepithelial neoplasia: A systematic review and meta‐analysis. International Journal of Gynecology & Obstetrics, 164(1), 66-74. https://doi.org/10.1002/ijgo.14953

Vancouver

van de Sande AJM, Kengsakul M, Koeneman MM, Jozwiak M, Gerestein CG, Kruse AJ, et al. The efficacy of topical imiquimod in high‐grade cervical intraepithelial neoplasia: A systematic review and meta‐analysis. International Journal of Gynecology & Obstetrics. 2024;164(1):66-74. doi:10.1002/ijgo.14953

BibTeX
@article{vandeSande2024,
  author = {van de Sande, A J M and Kengsakul, M and Koeneman, M M and Jozwiak, M and Gerestein, C G and Kruse, A J and van Esch, E M G and de Vos van Steenwijk, P J and Muntinga, C L P and Bramer, W M and van Doorn, H C and van Kemenade, F J and van Beekhuizen, H J},
  title = {The efficacy of topical imiquimod in high‐grade cervical intraepithelial neoplasia: A systematic review and meta‐analysis},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2024},
  volume = {164},
  number = {1},
  pages = {66--74},
  doi = {10.1002/ijgo.14953}
}
Kostenlos starten →